SOPHiA GENETICS SA

NASDAQ:SOPH

3.52 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 15.85315.80815.77917.04816.30315.05413.96613.38411.64811.66710.86110.93710.35910.1788.9767.8357.1685.9167.481
Cost of Revenue 5.1995.0325.3745.1495.035.0074.2723.7534.3554.0474.1514.1073.8153.9483.3592.9452.9011.952.913
Gross Profit 10.65410.77610.40511.89911.27310.0479.6949.6317.2937.626.716.836.5446.235.6174.894.2673.9664.568
Gross Profit Ratio 0.6720.6820.6590.6980.6910.6670.6940.720.6260.6530.6180.6240.6320.6120.6260.6240.5950.670.611
Reseach & Development Expenses 7.8747.9589.3919.768.9848.8919.3346.7910.1168.999.4756.3587.6556.3856.185.1715.0213.7654.631
General & Administrative Expenses 010.58312.82513.26912.74914.04113.24213.92912.80914.69714.3812.95911.6898.2248.6336.8244.6173.5224.002
Selling & Marketing Expenses 07.2586.9517.9666.837.2036.4244.2477.9218.2357.8648.5747.7067.5734.8824.2284.0663.7885.35
SG&A 18.18617.84119.77621.23519.57921.24419.66618.17620.7322.93222.24421.53319.39515.79713.51511.0528.6837.319.352
Other Expenses 0-0.8120000-0.019-0.2520.086-0.2230.012-0.052-0.004-0.028-0.024-0.268-0.006-0.0690.214
Operating Expenses 26.0625.79929.16730.99527.81730.09428.98124.71430.93231.69931.73127.83927.04622.15419.67115.95513.69811.00614.197
Operating Income -15.406-15.023-18.762-19.096-16.544-20.047-19.287-15.083-23.639-24.079-25.021-21.009-20.502-15.924-14.054-11.287-9.431-7.04-9.629
Operating Income Ratio -0.972-0.95-1.189-1.12-1.015-1.332-1.381-1.127-2.029-2.064-2.304-1.921-1.979-1.565-1.566-1.441-1.316-1.19-1.287
Total Other Income Expenses Net -2.902-0.0095.374-4.9573.019-1.276-0.3060.8550.224-0.608-0.233-0.89-0.263-2.4261.561-1.334-1.039-0.797-0.89
Income Before Tax -18.308-15.032-13.388-24.053-13.525-21.323-19.593-14.228-23.415-24.687-25.254-21.899-20.765-18.35-12.493-12.399-10.47-7.837-10.519
Income Before Tax Ratio -1.155-0.951-0.848-1.411-0.83-1.416-1.403-1.063-2.01-2.116-2.325-2.002-2.005-1.803-1.392-1.583-1.461-1.325-1.406
Income Tax Expense 0.130.1610.3160.0080.2990.0730.107-0.257-0.105-0.0060.233-0.5250.4780.040.175-1.918-0.0040.0180.018
Net Income -18.438-15.193-13.704-24.061-13.824-21.396-19.7-13.971-23.31-24.681-25.487-21.374-21.243-18.39-12.668-10.481-10.466-7.855-10.537
Net Income Ratio -1.163-0.961-0.868-1.411-0.848-1.421-1.411-1.044-2.001-2.115-2.347-1.954-2.051-1.807-1.411-1.338-1.46-1.328-1.409
EPS -0.28-0.23-0.21-0.37-0.21-0.33-0.31-0.22-0.36-0.39-0.4-0.39-0.35-0.29-0.26-0.22-0.22-0.16-0.27
EPS Diluted -0.28-0.23-0.21-0.37-0.21-0.33-0.31-0.22-0.36-0.39-0.4-0.39-0.35-0.29-0.26-0.22-0.22-0.16-0.27
EBITDA -16.095-12.986-16.703-17.115-14.343-17.783-17.397-15.083-22.194-22.692-23.833-21.14-19.504-15.222-13.374-13.642-8.816-6.493-9.044
EBITDA Ratio -1.015-0.821-1.059-1.004-0.88-1.181-1.246-1.127-1.905-1.945-2.194-1.933-1.883-1.496-1.49-1.741-1.23-1.098-1.209